文献速递糖尿病

基于视网膜、临床与基因组数据预测2型糖尿病患者主要不良心血管事件:一项人群队列研究

Prediction of Major Adverse Cardiovascular Events From Retinal, Clinical, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort Study.
PubMed 文献 · Diabetes Care · 2022-01-01

在GoDARTS队列5152例2型糖尿病患者中,1017例发生MACE。视网膜血管参数联合CHD多基因风险评分在调整年龄、性别、PCE和CHD PRS后仍可独立预测MACE(HR 1.11/SD,95%CI 1.04-1.18,P=0.002),联合模型AUC 0.686优于PCE的0.658(P<0.001)。

要点

  • 视网膜动脉分形维数和直径降低、静脉迂曲度增加各自独立预测MACE。
  • 视网膜参数风险评分联合CHD PRS较PCE改善MACE预测(AUC 0.686 vs 0.658,P<0.001)。
  • 视网膜参数评分单独与PCE预测准确性相似(AUC 0.663 vs 0.658,P=0.33)。

核心结论

  • 视网膜参数单独或联合全基因组CHD多基因风险评分,较传统心血管风险评估在2型糖尿病中具有独立且增量的预后价值。

研究设计与样本

  • 研究为人群队列研究,纳入苏格兰GoDARTS研究中5152例无既往心血管疾病的2型糖尿病患者,链接视网膜照片、处方和结局数据。
  • 使用VAMPIRE半自动人工智能平台分析视网膜照片,计算动脉和静脉的分形维数、迂曲度和直径;CHD PRS源自既往发表数据。
  • 采用多变量Cox回归评估视网膜血管参数与10年MACE的关联,并与汇总队列方程(PCE)风险评分比较。

主要发现

  • 5152例受试者中1017例发生MACE。
  • 动脉分形维数和直径降低、静脉迂曲度增加各自独立预测MACE。
  • 联合这些参数的风险评分在调整年龄、性别、PCE和CHD PRS后显著预测MACE(每增加1个标准差,HR 1.11,95%CI 1.04-1.18,P=0.002),准确性与PCE相似(AUC 0.663 vs 0.658,P=0.33)。
  • 包含视网膜参数和PRS的模型较PCE改善MACE预测(AUC 0.686 vs 0.658,P<0.001)。

关键数值与推荐

  • 视网膜参数联合评分每增加1个标准差,MACE风险HR 1.11(95%CI 1.04-1.18,P=0.002)。
  • 视网膜参数评分单独预测MACE的AUC为0.663,PCE为0.658(P=0.33)。
  • 视网膜参数联合PRS模型预测MACE的AUC为0.686,PCE为0.658(P<0.001)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Improved identification of individuals with type 2 diabetes at high cardiovascular (CV) risk could help in selection of newer CV risk-reducing therapies. The aim of this study was to determine whether retinal vascular parameters, derived from retinal screening photographs, alone and in combination with a genome-wide polygenic risk score for coronary heart disease (CHD PRS) would have independent prognostic value over traditional CV risk assessment in patients without prior CV disease. RESEARCH DESIGN AND METHODS: Patients in the Genetics of Diabetes Audit and Research Tayside Scotland (GoDARTS) study were linked to retinal photographs, prescriptions, and outcomes. Retinal photographs were analyzed using VAMPIRE (Vascular Assessment and Measurement Platform for Images of the Retina) software, a semiautomated artificial intelligence platform, to compute arterial and venous fractal dimension, tortuosity, and diameter. CHD PRS was derived from previously published data. Multivariable Cox regression was used to evaluate the association between retinal vascular parameters and major adverse CV events (MACE) at 10 years compared with the pooled cohort equations (PCE) risk score. RESULTS: Among 5,152 individuals included in the study, a MACE occurred in 1,017 individuals. Reduced arterial fractal dimension and diameter and increased venous tortuosity each independently predicted MACE. A risk score combining these parameters significantly predicted MACE after adjustment for age, sex, PCE, and the CHD PRS (hazard ratio 1.11 per SD increase, 95% CI 1.04-1.18, P = 0.002) with similar accuracy to PCE (area under the curve [AUC] 0.663 vs. 0.658, P = 0.33). A model incorporating retinal parameters and PRS improved MACE prediction compared with PCE (AUC 0.686 vs. 0.658, P < 0.001). CONCLUSIONS: Retinal parameters alone and in combination with genome-wide CHD PRS have independent and incremental prognostic value compared with traditional CV risk assessment in type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Mordi IR, Trucco E, Syed MG, et al. Prediction of Major Adverse Cardiovascular Events From Retinal, Clinical, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort Study. Diabetes Care. 2022. PMID: 35043139. doi:10.2337/dc21-1124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。